ClinicalTrials.gg
TerminatedNCT04504474Updated Oct 5, 2026

Network Analysis of Adult MDD and ADHD

An observational study in ADHD, sponsored by Health Sciences North Research Institute. Terminated at 1 site in Canada. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Health Sciences North Research Institute · Observational

How we know

Why this study was terminated
The Health Sciences North Research Ethics Board (HSN REB) has recommended termination of approval for the research project, because it has surpassed the stated date of expiry for renewal.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
1
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada — 12 open to participants now, 16 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Canada.

Enrollment
13th of 13
1 · median 195
Started
2018
with 4 others
Observational
13 of 85
4 open now
Registered
63rd of 85
by date

Among the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada, this one is the 13th largest by enrollment of the 13 observational ones that give a count, is one of 5 that started in 2018, is one of 13 observational ones, and was the 63rd registered.

Attention Deficit Disorder with Hyperactivity

1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.

Browse Attention Deficit Disorder with Hyperactivity studies →

Open to participants now

12 of the 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Attention Deficit Disorder with Hyperactivity with a site in Canada, or all of them as a file.
02

Study summary

The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.

03

Conditions studied

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We will gather a recruitment of 500 male and female outpatients from the Psychiatric Outpatient Clinic at Kirkwood Site attached to Health Sciences North.

Eligibility criteria

Inclusion Criteria:

  • participants have a diagnosis of MDD or ADHD or both
  • participants are competent to consent to the study
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
1 participant (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Co-morbidity

    Characterize the ADHD/MDD symptom network in a psychiatric outpatient setting comprised of adults

    Time frame: September 8, 2021

  2. Network reliability

    Determine the stability and reliability of this network

    Time frame: September 8, 2021

  3. Central symptoms

    Determine the central symptoms that lead to co-activation of ADHD/MDD clusters

    Time frame: September 8, 2021

07

Study locations

1 site
  • Kirkwood Site - Health Sciences North
    Greater Sudbury, Ontario P3E 1X3, Canada
08

References and documents

Individual participant data

Plan to share: No — None of the IPD will be shared with other researchers

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2018 to primary completion in Dec 2023, 65 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2020
First posted
Aug 7, 2020
StartActual
Jun 21, 2018
Primary completionActual
Dec 4, 2023
CompletionActual
Dec 4, 2023
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04504474
Lead sponsor
Health Sciences North Research Institute
Responsible party
Sponsor
First posted
Aug 7, 2020
Start date
Jun 21, 2018
Primary completion
Dec 4, 2023
Completion
Dec 4, 2023
Last update
Oct 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion